AFP and hepatocellular carcinoma: Results from other studies also showed the AFP level was an important prediction factor for the recurrence and prognosis of HCC after resection, transarterial chemoembolization (TACE) or radiofrequency ablation (RFA) treatment [6,14-16], and it could be used to evaluate the prognosis of HCC as an independent influential factor [17,18].